Physician profile
Robert W Halsted
NPI 1447286380
$1,211.84
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $110 · 2021: $272 · 2022: $215 · 2023: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $374.94 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $196.89 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $106.53 | 2023 | Xarelto |
| Novo Nordisk INC | $72.76 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.72 | 2019-2023 | Jardiance |
| Amgen INC. | $65.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $50.37 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $37.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $33.35 | 2022 | |
| Lilly USA, LLC | $30.06 | 2023 | Trulicity, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $28.19 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $24.42 | 2019-2020 | |
| Nevro Corp. | $17.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.61 | 2021 | |
| Electromed, INC. | $14.12 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.29 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.30 | 2022 | |
| Pfizer INC. | $11.76 | 2022 | |
| Glaxosmithkline, LLC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Halsted listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.